Keywords
intravenous thrombolysis
cerebral hemorrhage
Categories
How to Cite
Abstract
Introduction: Ischemic stroke has a poor prognosis and is a heavy burden for society. Hemorrhagic transformation after intravenous thrombolysis may increase morbidity and mortality in these patients. Materials and Methods: Using a retrospective analysis, related risk factors were recruited for analysis, including smoking, alcohol consumption, hyperlipidemia, diabetes, history, and pathological indicators. Statistical analysis was performed using ANOVA for quantitative variables and chi-square for qualitative variables. Results: We studied 52 patients with acute ischemic stroke treated with recombinant tissue-type plasminogen activator (rt-PA) within 4.5 h of symptom onset. Age ≥70 years, smoking, atrial fibrillation, NIHSS score before thrombolysis ≥20, and systolic pressure ≥160 mmHg during and 2 h after thrombolysis increased the risks of hemorrhagic transformation after thrombolysis. Conclusions: Knowledge of the risk factors associated with hemorrhagic transformation after treatment with rt-PA may help to develop treatment strategies and reduce the risk of these events. A better characterization of our Latin American patients will allow directing population strategies in these cohorts in a more individualized way. We encourage the development of studies of this nature in our lat
References
Modrego PJ. The risk of symptomatic intracranial hemorrhage after thrombolysis for acute stroke: Current concepts and perspectives. Ann Indian Acad Neurol [Internet]. 2019;22(3):336–40. Disponible en: http://dx.doi.org/10.4103/aian.AIAN_323_18
Charbonnier G, Bonnet L, Biondi A, Moulin T. Intracranial bleeding after reperfusion therapy in acute ischemic stroke. Front Neurol [Internet]. 2020;11:629920. Disponible en: http://dx.doi.org/10.3389/fneur.2020.629920
Tsivgoulis G, Kargiotis O, De Marchis G, Kohrmann M, Sandset EC, Karapanayiotides T, et al. Off-label use of intravenous thrombolysis for acute ischemic stroke: a critical appraisal of randomized and real-world evidence. Ther Adv Neurol Disord [Internet]. 2021;14:1756286421997368. Disponible en: http://dx.doi.org/10.1177/1756286421997368
Berge E, Whiteley W, Audebert H, De Marchis GM, Fonseca AC, Padiglioni C, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J [Internet]. 2021;6(1):I–LXII. Disponible en: http://dx.doi.org/10.1177/2396987321989865
Toyoda K, Koga M, Iguchi Y, Itabashi R, Inoue M, Okada Y, et al. Guidelines for intravenous thrombolysis (recombinant tissue-type plasminogen activator), the third edition, march 2019: A guideline from the japan stroke society. Neurol Med Chir (Tokyo) [Internet]. 2019;59(12):449–91. Disponible en: http://dx.doi.org/10.2176/nmc.st.2019-0177
Alamowitch S, Turc G, Palaiodimou L, Bivard A, Cameron A, De Marchis GM, et al. European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke. Eur Stroke J [Internet]. 2023;8(1):8–54. Disponible en: http://dx.doi.org/10.1177/23969873221150022
Han TS, Gulli G, Fry CH, Affley B, Robin J, Fluck D, et al. Adverse consequences of immediate thrombolysis-related complications: a multi-centre registry-based cohort study of acute stroke. J Thromb Thrombolysis [Internet]. 2022;53(1):218–27. Disponible en: http://dx.doi.org/10.1007/s11239-021-02523-2
Botelho A, Rios J, Fidalgo AP, Ferreira E, Nzwalo H. Organizational factors determining access to reperfusion therapies in ischemic stroke-systematic literature review. Int J Environ Res Public Health [Internet]. 2022;19(23). Disponible en: http://dx.doi.org/10.3390/ijerph192316357
Lin S-F, Chen C-F, Hu H-H, Ho B-L, Chen C-H, Chan L, et al. Comparison of different dosages of alteplase in atrial fibrillation-related acute ischemic stroke after intravenous thrombolysis: A nationwide, multicenter, prospective cohort study in Taiwan. J Am Heart Assoc [Internet]. 2022;11(3):e023032. Disponible en: http://dx.doi.org/10.1161/JAHA.121.023032
Bagoly Z, Szegedi I, Kálmándi R, Tóth NK, Csiba L. Markers of coagulation and fibrinolysis predicting the outcome of acute ischemic stroke thrombolysis treatment: A review of the literature. Front Neurol [Internet]. 2019;10:513. Disponible en: http://dx.doi.org/10.3389/fneur.2019.00513
Zhou Y, Yan S, Song X, Gong Y, Li W, Wang M, et al. Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers. BMC Neurol [Internet]. 2019;19(1):202. Disponible en: http://dx.doi.org/10.1186/s12883-019-1418-z
Evans, N. R., Sibson, L., Day, D. J., Agarwal, S., Shekhar, R., & Warburton, E. A. (2022). Hyperacute stroke thrombolysis via telemedicine: a multicentre study of performance, safety and clinical efficacy. BMJ open, 12(1), e057372. https://doi.org/10.1136/bmjopen-2021-057372
Ng SH-X, Wong AWK, Chen CH, Tan CS, Müller-Riemenschneider F, Chan BPL, et al. Stroke factors associated with thrombolysis use in hospitals in Singapore and US: A cross-registry comparative study. Cerebrovasc Dis [Internet]. 2019;47(5–6):291–8. Disponible en: http://dx.doi.org/10.1159/000502278
Herath, H. M. M. T. B., Rodrigo, C., Alahakoon, A. M. B. D., Ambawatte, S. B., Senanayake, S., Senanayake, B., & Fernando, A. (2021). Outcomes of stroke patients undergoing thrombolysis in Sri Lanka; an observational prospective study from a low-middle income country. BMC neurology, 21(1), 434. https://doi.org/10.1186/s12883-021-02475-3
Nordanstig A, Curtze S, Gensicke H, Zinkstok SM, Erdur H, Karlsson C, et al. EndoVAscular treatment and ThRombolysis for Ischemic Stroke Patients (EVA-TRISP) registry: basis and methodology of a pan-European prospective ischaemic stroke revascularisation treatment registry. BMJ Open [Internet]. 2021;11(8):e042211. Disponible en: http://dx.doi.org/10.1136/bmjopen-2020-042211
Koga M, Yamamoto H, Inoue M, Asakura K, Aoki J, Hamasaki T, et al. Thrombolysis with alteplase at 0.6 mg/kg for stroke with unknown time of onset: A randomized controlled trial: A randomized controlled trial. Stroke [Internet]. 2020;51(5):1530–8. Disponible en: http://dx.doi.org/10.1161/STROKEAHA.119.028127
Fu Q, Wang X, Zhang D, Shi L, Wang W, Guo Z, et al. Improving thrombolysis for acute ischemic stroke: The implementation and evaluation of a theory-based resource integration project in China. Int J Integr Care [Internet]. 2022;22(1):9. Disponible en: http://dx.doi.org/10.5334/ijic.5616
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Luis Andres Dulcey Sarmiento